Your browser doesn't support javascript.
loading
Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids.
Magoulas, George E; Afroudakis, Pantelis; Georgikopoulou, Kalliopi; Roussaki, Marina; Borsari, Chiara; Fotopoulou, Theano; Santarem, Nuno; Barrias, Emile; Tejera Nevado, Paloma; Hachenberg, Julia; Bifeld, Eugenia; Ellinger, Bernhard; Kuzikov, Maria; Fragiadaki, Irini; Scoulica, Effie; Clos, Joachim; Gul, Sheraz; Costi, Maria Paola; de Souza, Wanderley; Prousis, Kyriakos C; Cordeiro da Silva, Anabela; Calogeropoulou, Theodora.
Afiliación
  • Magoulas GE; National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece.
  • Afroudakis P; National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece.
  • Georgikopoulou K; National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece.
  • Roussaki M; National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece.
  • Borsari C; Department of Biomedicine, University of Basel, 4058 Basel, Switzerland.
  • Fotopoulou T; National Hellenic Research Foundation, Institute of Chemical Biology, 11653 Athens, Greece.
  • Santarem N; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
  • Barrias E; Parasite Disease Group, IBMC-Instituto de Biologia Molecular e Celular, 4150-180 Porto, Portugal.
  • Tejera Nevado P; Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Bioimagens, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
  • Hachenberg J; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Ilha do Fundão, Rio Janeiro 21941-902, Brazil.
  • Bifeld E; Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
  • Ellinger B; Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
  • Kuzikov M; Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
  • Fragiadaki I; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 22525 Hamburg, Germany.
  • Scoulica E; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, 22525 Hamburg, Germany.
  • Clos J; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 22525 Hamburg, Germany.
  • Gul S; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, 22525 Hamburg, Germany.
  • Costi MP; Department of Clinical Microbiology and Microbial Pathogenesis, Faculty of Medicine, University of Crete, 70013 Heraklion, Greece.
  • de Souza W; Department of Clinical Microbiology and Microbial Pathogenesis, Faculty of Medicine, University of Crete, 70013 Heraklion, Greece.
  • Prousis KC; Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.
  • Cordeiro da Silva A; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, 22525 Hamburg, Germany.
  • Calogeropoulou T; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CIMD, 22525 Hamburg, Germany.
Molecules ; 26(14)2021 Jul 10.
Article en En | MEDLINE | ID: mdl-34299479
ABSTRACT
A library of seventeen novel ether phospholipid analogues, containing 5-membered heterocyclic rings (1,2,3-triazolyl, isoxazolyl, 1,3,4-oxadiazolyl and 1,2,4-oxadiazolyl) in the lipid portion were designed and synthesized aiming to identify optimised miltefosine analogues. The compounds were evaluated for their in vitro antiparasitic activity against Leishmania infantum and Leishmania donovani intracellular amastigotes, against Trypanosoma brucei brucei and against different developmental stages of Trypanosoma cruzi. The nature of the substituents of the heterocyclic ring (tail) and the oligomethylene spacer between the head group and the heterocyclic ring was found to affect the activity and toxicity of these compounds leading to a significantly improved understanding of their structure-activity relationships. The early ADMET profile of the new derivatives did not reveal major liabilities for the potent compounds. The 1,2,3-triazole derivative 27 substituted by a decyl tail, an undecyl spacer and a choline head group exhibited broad spectrum antiparasitic activity. It possessed low micromolar activity against the intracellular amastigotes of two L. infantum strains and T. cruzi Y strain epimastigotes, intracellular amastigotes and trypomastigotes, while its cytotoxicity concentration (CC50) against THP-1 macrophages ranged between 50 and 100 µM. Altogether, our work paves the way for the development of improved ether phospholipid derivatives to control neglected tropical diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_chagas_disease / 3_neglected_diseases / 3_zoonosis Asunto principal: Fosfolípidos / Diseño de Fármacos / Leishmaniasis / Enfermedad de Chagas / Macrófagos / Antiparasitarios Tipo de estudio: Evaluation_studies Límite: Humans Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Grecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 / 3_ND Problema de salud: 2_enfermedades_transmissibles / 3_chagas_disease / 3_neglected_diseases / 3_zoonosis Asunto principal: Fosfolípidos / Diseño de Fármacos / Leishmaniasis / Enfermedad de Chagas / Macrófagos / Antiparasitarios Tipo de estudio: Evaluation_studies Límite: Humans Idioma: En Revista: Molecules Asunto de la revista: BIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Grecia
...